● Recruiting

Electronic Cigarettes as a Harm Reduction Strategy Among People With Opioid Use Disorder on Buprenorphine

Condition: Tobacco-flavored EC · Sweet-Cooling EC · Sweet Non-cooling EC · Sponsor: Prisma Health-Upstate

PhaseNA

Planned participants90

Who can joinAll sexes, 21 Years to no upper limit

Healthy volunteersNo

About this study

This project aims to investigate the impact of e-cigarette flavors and usage patterns on achieving harm-reduction milestones in a sample of cigarette smokers with opioid use disorder who are taking buprenorphine

This description comes directly from the study's public registry record.

Talk to the study team

Irene Pericot-Valverde, PhD · (864)656-4467 · iperico@clemson.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Addiction Medicine Center

Greenville, South Carolina, United States

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07202039